Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 4/20 | 0.61 |
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | EGFR | P00533 | 2/20 | 0.61 |
| ▸ | FYN | P06241 | 2/20 | 0.61 |
| ▸ | MMP9 | P14780 | 2/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | CDK2 | P24941 | 2/20 | 0.61 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4540573 | 0.92 | LMNA (0.56) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL9768108 | 0.84 | ALDH1A1 (0.50) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL396882 | 0.83 | ALDH1A1 (0.52) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL7159393 | 0.82 | CYP1A2 (0.56) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL8977713 | 0.81 | ALDH1A1 (0.52) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL5401074 | 0.81 | MEN1 (0.54) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL1244366 | 0.80 | LMNA (0.61) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL6243158 | 0.79 | ERN1 (0.62) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL9095874 | 0.79 | BACE1 (0.50) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL18197 | 0.79 | CA2 (0.62) | LMNAALDH1A1HPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114075335-B | Polyphenyl ether resin, resin composition containing polyphenyl ether resin and product | 台光电子材料(昆山)有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115490847-A | Sulfone-containing dihydroxy polyphenyl ether, crosslinkable polyphenyl ether and preparation method thereof | 四川轻化工大学 | 2022-12-20 | — | — | CN | claimed |
| CN-109988299-B | Epoxy-containing organic silicon modified polyphenyl ether resin and preparation method and application thereof | 广东生益科技股份有限公司 | 2021-10-19 | — | — | CN | claimed |
| CN-107353401-B | Dihydroxy polyphenyl ether and preparation method thereof | 宋立旺 | 2020-06-30 | — | — | CN | claimed |
| EP-0853104-B1 | Liquid dyestuff compositions | CLARIANT FINANCE BVI LTD (VG) | 2001-12-12 | — | — | EP | claimed |
| US-6221113-B1 | A LIQUID DYE FORMULATION COMPRISING A BASIC OR CATIONIC WATER SOLUBLE DYESTUFF, AN ACID EXCLUDING PHENOLIC COMPOUNDS AND A PHENOLIC DERIVATIVE SELECTED FROM ORCINOL, GALLIC ACID, GALLIC ACID ESTER OR AMIDE, HYDROQUINONE, PYROGALLOL ETC. | CLARIANT FINANCE (BVI) LIMITED (VG) | 2001-04-24 | — | — | US | claimed |
| US-5965688-A | FORMING AN ALIPHATIC CHLOROFORMATE AND THEN REACTING THE BISCHLOROFORMATE WITH AROMATIC DIOL IN AN INTERFACIAL POLYMERIZATION REACTION TO FORM A COPOLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 1999-10-12 | — | — | US | claimed |
| EP-0853104-A2 | Liquid dyestuff compositions | Clariant Finance (BVI) Limited (VG) | 1998-07-15 | — | — | EP | claimed |
| JP-2036990-A | — | — | None | — | — | JP | disclosed |
| JP-61212544-A | — | — | None | — | — | JP | disclosed |
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | WILLIAMS RICHARD KENT (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025128460-A1 | ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF | WILLIAMS RICHARD KENT (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-112513737-B | Underlayer film forming composition | 三菱瓦斯化学株式会社 | 2024-11-15 | — | — | CN | disclosed |
| US-20240109997-A1 | RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD AND METHOD FOR PURIFYING RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-04-04 | — | — | US | disclosed |
| US-4483961-A | Polymeric cyclopentadiene derivatives, method for preparing and use thereof | ASHLAND OIL, INC. (US) | 1984-11-20 | — | — | US | disclosed |
| US-4482653-A | Cyclopentadiene derivatives, method for preparing, and use thereof | ASHLAND OIL, INC. (US) | 1984-11-13 | — | — | US | disclosed |
| US-4412088-A | CURABLE BINDER COMPOSITIONS | ASHLAND OIL, INC. (US) | 1983-10-25 | — | — | US | disclosed |
| EP-0090404-A1 | Poly(aryl ether)polymer containing compositions | AMOCO CORPORATION (US) | 1983-10-05 | — | — | EP | disclosed |
| US-4001183-A | 1,4-BIS(4',4'-DIHYDROXY-TRIPHENYL-METHYL)-BENZENE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |
| US-3959404-A | Powder coating compositions containing glycidyl ester copolymers and phenolic hydroxy terminated crosslinking agent | FORD MOTOR COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | MYOC, MB, MYOF | LMNA 32/4885ALDH1A1 4755/4885HPGD 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.